MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

Condition:   Anal Squamous Cell Carcinoma Interventions:   Radiation: Radiotherapy - Low risk group;   Radiation: Radiotherapy - Standard risk group;   Radiation: Radiotherapy - Intermediate risk group;   Radiation: Radiotherapy - High risk group Sponsor:   University Health Network, Toronto Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials